News and Comments

New Development in Amgen offer To Acquire Onyx

  Sunday, June 30, 2013

In a new development, Onyx (ONXX) confirmed Amgen’s offer in the same release that announced rejecting it. Indeed, Onyx has rejected Amgen’s unsolicited proposal that suggests acquiring Onyx’s outstanding shares and share equivalents for $120 per share in cash, subject to due diligence and other conditions.  More...


  Sunday, June 30, 2013

In November 2011 Prohost posted an article titled “Deal or no deal, time for a payoff” (click HERE to read the article). All that prophesized in that article about Onyx’ (ONXX) drugs and prospects has materialized and the final item, a takeover, seems to be on the verge of happening.   More...

Two Small Great Biotechs Underestimated by the Market

  Tuesday, June 25, 2013

Seattle Genetics’ (SGEN) and ImmunoGen’s (IMGN) conjugated monoclonal antibody therapeutics for cancer are increasingly validating their superior safety and efficacy over other cancer products that are used without the antibody drug conjugates (ADC).  More...

Why Amgen and Cytokinetics Agreement is Good News?

  Wednesday, June 12, 2013


Recent Postings



ZALTRAP™ ADVENTRIX (ANX) Idenix (IDIX) IDERA (IDRA) Vitae Pharmaceuticals (VTAE) Endometrial Cancer Biocryst (BCRX) Agenus (AGEN) Dynavax (DVAX) ACADIA (ACAD) SYNTA (SNTA) Theravance Bio Pharma (TBPH) Rapamune Elan (ELN) Bristol-Myers Squibb (BMY) VANDA (VNDA) Sanofi (SNA) Theravance (THRX) Sequenom (SQNM) Mirati Therapeutics (MRTX) SUNESIS PHARMACEUTICALS (SNSS) Inovio (INO) INNOVIVA (INVA) Sanofi-Aventis (SAN) ARGOS (ARGS) Ziofpharm (ZIOP) KERYX (KERX) SERES THERAPEUTICS (MCRB) NEKTAR (NKTR)) Agenus (AGEN Onyx (ONXX) Tysabri Global Cell Therapeutics (GBT) AERIE PHARMACEUTICALS Ionis (IONS) Xoma (XOMA) Merck (MRK) TOKAI (TKAOI) Editas (EDIT) Roche (RHHBY) Alnylam (ALNY) Telaprevir Herceptin ISIS (ISIS) Multiple Myeloma AGOS (ARGS) Auspex (ASPX) galapagos (GLPG) C4 Therapeutics PTC Therapeutics (PTCT) Pluristem (PSTI) Micromet (MITI) Anacor (ANAC) Prosensa (RNA) Intrexon (XON) Prolor Biotech (PBTH) Ariad (ARIA) Spike Therapeutics (ONCE) Cytokinetics (CYTK) Seattle Genetics (SGEN) Exelixis (EXEL) Vertex (VRTX) Aimmune Therapeutics (AIMT) Intermune (ITMN) ABBVIE (ABBV) HALOZYME (HALO) Human Longevity (HLI) Illumina (ILMN) NANTKWEST (NK) Intercept (ICPT) Incyte (INCY) Sarepta (SRPT) Gilead (GILD) ImmunoGen (IMGN) Biogen Idec (BIIB) Dendreon (DNDN) Valeant Pharmaceuticals International (VRX) Jazz Pharmaceuticals (JAZZ) Array Pharmaceuticals (ARRY) Benlysta (belimumab) RenenxBio (RGNX) Revlimid (lenolidamide) Zerenex GlaxoSmithKline (GSK) Amgen (AMGN) Genentech Ridaforolimus Regeneron (REGN) Human Genome Sciences (HGSI) ARCA (ABIO) Anadys (ANDS) OSI (OSIP) REGULUS (RGLS) Sanofi (SNY) Galena (GALE) Sangamo (SGMO) JUNO (JUNO) Trastuzumab-DM1 Alder Biopharmaceuticals (ALDR) Roche (ROCHE) BIOMARIN (BMRN) Velcade (bortezomib) Abbott Laboratories (ABT) GUARDIAN HEALTH KITE (KITE) CompuGen (CGEN)